According to a new report from Intel Market Research, the global Mitoxantrone Hydrochloride Injection market was valued at USD 197 million in 2025 and is projected to reach USD 324 million by 2034, growing at a CAGR of 5.7% during the forecast period (2026–2034). This expansion is driven by rising global cancer incidence, healthcare infrastructure expansion in emerging economies, and...